Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs

Emcdda — European Monitoring Centre For Drugs And Drug Addiction

Description

EMCDDA Risk assessments
Medical and biological research
Health policy
Social policy
Target audience: Scientific

Sujets

• Pharmacology
• Toxicology
• Narcotic
• Health care system
• Drug
• Report

Informations

• Publié par: EMCDDA-EUROPEAN-MONITORING-CENTRE-FOR-DRUGS-AND-DRUG-ADDICTION
• Nombre de lectures: 19
• Langue: English

Extrait

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is one of the decentralised agencies set up by the European Union to carry out specialised technical or scientific work.

Its role is to gather, analyse and disseminate ‘objective, reliable and comparable information’ on drugs and drug addiction and, in doing so, provide its audiences with a sound and evidence-based picture of the drug phenomenon at European level.

Among the Centre’s target groups are policy-makers who use this information to help formulate coherent national and Community drug strategies. Also served are professionals and researchers working in the drugs field and, more broadly, the European media and general public.

EMCDDA risk assessments are publications examining the health and social risks of individual synthetic drugs on the basis of research carried out by the agency and its partners.

ISBN 92-9168-137-7 ,!7IJ2J1-gibdhc! >

E M C D D A RISK ASSESSMENTS

Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs